Managing Acute and Perioperative Pain in Patients on Medication-Assisted Treatments (MAT)

This webinar will discuss the best evidence for management of acute and perioperative pain for patients on buprenorphine, methadone and  naltrexone formulations for substance use disorders. We will cover strategies for patient preparation and communication with the perioperative team. 


    ASAM and/or CSAM Members: Free
    Non-Member: $50.00

    You must register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart." 


    This enduring internet activity is jointly provided by the California Society of Addiction Medicine (CSAM) and the California Health Care Foundation. CSAM is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.

    CSAM designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.

    PA’s, nurses, pharmacists, psychologists and therapists can earn CEU credit.

    Target Audience

    1. Primary care physicians who are implimenting medication assisted treatment of opioid dependence.
    2. Other clinicians who see patients dependent on opioids.

    Learning Objectives

    1. Be more confident addressing acute pain in patients on buprenorphine products for opioid use disorder and for patients on naltrexone formulations.
    2. Regarding patients on methadone, be more aware of  the perioperative implications of this medication.
    3. Understand  the evidence-base for how to approach perioperative pain in patients on buprenorphine.
    Course summary
    Available credit: 
    • 1.00 AMA Category 1
    • 1.00 Attendance
    Course opens: 
    Course expires: 

    Andrea Rubinstein, MD
    Chief, Department of Chronic Pain, Kaiser Permanente Santa Rosa Medical Center; Assistant Clinical Professor of Family and Community Medicine, UC San Francisco

    Dr. Rubinstein and the Planners of this activity have no relevant financial relationships to disclose

    Available Credit

    • 1.00 AMA Category 1
    • 1.00 Attendance


    Please login or register to take this course.